The classification of HLA-DPB1 mismatches based on T-cell-epitope groups (TCE-Groups) helps determine mismatches that may be tolerated (permissive) and those that increase the risk (non-permissive) of acute GvHD. This evidence concerns the gene HLA-DPB1 and graft versus host disease.